Navigation Links
CPhI Announces its 2nd Annual Global Pharma Regulatory Summit

MUMBAI, February 11, 2013 /PRNewswire/ --

CPhI Conferences announces the 2nd Global Pharma Regulatory Summit, which is now transformed into a week-long summit, taking place from 11-15 March 2013 at Holiday Inn Mumbai International Airport, Mumbai, India. The format of the conference is as follows:

· Pre-conference seminar - GDUFA 
· Conference Day One - US focused day
· Conference Day Two - EU focused day
· Conference Day Three - RoW regulations
· Workshop - eCTD Lifecycle Management


This regulatory-focused summit has received a lot of interest and has already confirmed industry leaders to be present including, Ashish Kohli , Director - EU Regulatory Strategy, Pfizer UK;  Imtiyaz Basade , Senior Vice President - Regulatory Affairs, Mylan Laboratories;  Praveen Khullar , Senior Director Development Centre, Sanofi Synthelaboe; Dr. Rajkiran Jain , Head - International Regulatory Affairs, Zydus Cadila; Dr. Hoss Dowlat , Vice President, PharmaBio Consulting (Lifesciences) GermanyNaveen Kumar Jain , Associate Director - Regulatory Affairs, Dr. Reddy's Laboratories and many more.

This event features in-depth discussions on specific regulatory challenges faced by pharma companies in US, Europe and RoW markets. First two days of the conference are dedicated to the US and EU markets respectively. The complexities involved in US and EU regulations around DMF, ANDA, QbD, and Variation regulations will also be addressed. Third day of the conference focuses on regulations for RoW markets including LATAM, ASEAN, Turkey, MENA, South Africa, Russia/CIS and many more. 

In addition to this event, there are two unique interactive sessions - pre-conference seminar on GDUFA presented by Arvind Mishra, Joint President - Corporate QA/QC and RA, Cadila Pharmaceuticals and many more. Also, post-conference workshop on eCTD Lifecycle Management taken up by Jasbir Chohan , Director - Regulatory Operations, Pharmaceutical eConsulting, UK and Chikkam Rama Mohan Rao, Director - RA operations, Novo Nordisk.

This week-long summit has already registered more than 80 attendees including companies like Cipla, Piramal Healthcare, Glenmark Generics, Beximco, Alkem, Cadila, Famycare and will help you understand and clarify stringent regulatory requirements to enhance exports in the high potential regulated and semi-regulated markets.

Find out more about 2nd Global Pharma Regulatory Summit at

About CPhI

CPhI is a UBM brand, and is the largest and most important meeting place for the Indian pharma industry. Each year, CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian Pharma industry. 

About UBM India

UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit the UBM India website,

Primary Media Contact: Shwetha Prabhu ,, 91-22-61727001

SOURCE UBM India Pvt. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
2. NASP Announces Partnership with Gerry Crocker to Advance Specialty Pharmacy Industry
3. American Outcomes Management, L.P. announces the appointment of Patrick S. Smith as President and Chief Operating Officer
4. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
5. IMD Companies, Inc. (ICBU) Announces Procedure for Issuance of Positive Solutions Stock
6. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
7. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
8. Accuray Announces Results for Second Quarter Fiscal 2013
9. Accuray Announces Proposed Offering Of $75 Million Of Convertible Senior Notes
10. Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook
11. Echo Therapeutics Announces Closing of Public Offering of Common Stock
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Today AVACEN Medical announced the issue of United ... Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat therapy ... Method. Photo - ... ... ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) today ... will discuss corporate updates at the 27 th Annual ... on Wednesday, December 2, 2015 at 1 p.m. ET. ... then the link to the event. Participants should allow approximately ... the site and download any streaming media software needed to ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... As ... Water For Empowerment ™ attracts volunteers together who want to combine talents and ... as key stakeholders in the process. The non-profit launched its first major fundraiser ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... 2015 , ... In an ongoing Clinical Study conducted by an independent physician, ... Angel is evaluating the efficacy of its product and its disinfection protocol. This study ... from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located ...
Breaking Medicine News(10 mins):